Program - Congress Business Travel

6th European American
Congress on Venous Diseases
together with
30th Annual Congress of the
Czech Society of Phlebology
PROGRAMME
under the auspices of
Prof. Josef Koutecký, MD, DSc
Dean of the 2nd Faculty of Medicine, Charles University
Prof. Jaroslav Blahoš, MD, DSc
President of the Czech Medical Association J. E. Purkyně
Congress Presidents
Prague,
Jaroslav Strejček, MD, PhD
Centre for Dermatological Angiology, Prague,
Czech Republic
Czech Republic
Mitchel P. Goldman, MD
26th – 28th May
Spa MD, La Jolla, California, U.S.A.
2005
www.cbttravel.cz/flebo05
j e d i n é
m i k r o n i z o v a n é
v e n o t o n i k u m
Výhodnější balení
pro dlouhodobou léčbu
60
tablet
SloÏení a balení: Mikronizovaná, purifikovaná flavonoidní frakce; 500 mg v 1 tabletû: diosmin 450 mg, flavonoidy vyjádfiené
ve formû hesperidinu 50 mg; 30 nebo 60 potahovan˘ch tablet v jednom balení. Farmakologické vlastnosti: Venotonikum
a vazoprotektivum. Detralex pÛsobí na Ïilní návrat; sniÏuje Ïilní distenzibilitu a venostázu; normalizuje kapilární permeabilitu
a zvy‰uje kapilární rezistenci; zvy‰uje lymfatick˘ prÛtok. Indikace: Léãba pfiíznakÛ a projevÛ chronické Ïilní insuficience dolních konãetin, funkãních nebo organick˘ch: pocit tíhy, bolest, kfieãe, edém, trofické zmûny, vãetnû bércového vfiedu. Léãba pfiíznakÛ a projevÛ hemoroidálního onemocnûní, vãetnû léãby akutní hemoroidální ataky. Pfiípravek je urãen dospûl˘m pacientÛm.
NeÏádoucí úãinky: Byly popsány lehké gastrointestinální (nauzea, vomitus, dyspepsie, gastralgie) a neurovegetativní (závratû, bolesti hlavy) neÏádoucí úãinky, které nevyÏadují pfieru‰ení léãby. Interakce: Îádné. Tûhotenství a kojení: Ve studiích,
kdy se pfiípravek podával tûhotn˘m Ïenám i Ïenám po porodu, nedo‰lo k Ïádnému nepfiíznivému ovlivnûní tûhotenství ani plodu. Postnatální experimentální studie neprokázaly Ïádné anatomické anomálie ani potíÏe v chování mláìat bûhem období kojení. Kontraindikace: Známá nebo pfiedpokládaná pfiecitlivûlost na úãinnou látku nebo pomocné látky. Dávkování a zpÛsob
podání: Venolymfatická insuficience: 2 tablety dennû. Akutní hemoroidální ataka: 6 tablet dennû bûhem prvních 4 dnÛ, poté
4 tablety dennû bûhem následujících 3 dnÛ. UdrÏovací dávka: 2 tablety dennû. Podmínky uchovávání: Pfii teplotû do 30 °C.
Úplná informace pro pfiedepisování viz Souhrn údajÛ o pfiípravku. Datum poslední revize textu: 02/2004. Pfiípravek je k dispozici v lékárnách na lékafisk˘ pfiedpis. Pfiípravek je ãásteãnû hrazen z prostfiedkÛ vefiejného zdravotního poji‰tûní. Registraãní ãíslo: 85/392/91-C. DrÏitel registraãního rozhodnutí: Les Laboratoires Servier, 22, rue Garnier, 92 200 Neuilly-sur-Seine,
Francie. Dal‰í informace na adrese: Servier s. r. o., Praha City Center, Klimentská 46, 110 02 Praha 1,
2
SERVIER
tel.: 222 118 510, fax: 222 118 501. www.servier.cz
Congress Presidents’ Greetings
Dear Colleagues,
Welcome to Prague – to the 6th European-American Congress (formerly Symposium) on Venous
Diseases (EACVD). We would like to greet you all in the name of the Czech Society of Phlebology
(CSP), which celebrates its 40th anniversary this year. The CSP has been a member of the International
Union of Phlebology for many years and actively participates in all UIP activities.
The tradition of international meetings on phlebology started in the Czech Republic (former
Czechoslovakia) in September 1975. During this legendary International Conference on Phlebology
organized by Dr. Maruše Horáková there was active participation by the world leaders of phlebology:
Drs. Bassi, Davy, Ouvry, Hach, Perrin, Rada, Tournay, Wallois.
The Board of Directors of the CSP decided to celebrate the anniversary of this meeting by restoring
the interrupted tradition of the European-American Congresses on Venous Diseases. The last EACVD
was organized by Prof. Hugo Partsch in Vienna in 1990 under the supervision of the Phlebological
Section of the Austrian Society of Dermatology and Venerology and we hope that the 6th EACVD will
successfully continue the transatlantic exchange of scientific information that was started many years ago.
We are very happy, that our invitation to Prague was accepted by such celebrities of international
phlebology as Prof. Claudio Allegra (Italy), President of International Union of Phlebology, Prof. Hugo
Partsch (Austria), Past-President of UIP, Prof. Arkadiusz Jawien (Poland), President of the European
Venous Forum, Dr. Albert Adrien Ramelet (Switzerland) and Prof. Eberhard Rabe (Germany), VicePresidents of the UIP, Prof. Sanja Schuller-Petrovic (Austria), Head of Austrian Phlebology, Dr. Angelo
Scuderi (Brazil), President of the XV. World Congress Rio UIP 2005 and others.
As we mentioned in our invitation, the most beautiful time to visit Prague is in May, so we hope that
you all will enjoy not only the scientific and social program we have prepared for you, but also the spring
atmosphere of Prague, one of the most beautiful cities of the world.
Jaroslav Strejcek
Mitchel P. Goldman
3
Committees & Contacts
Congress President
Jaroslav Strejček, MD, PhD
Centre for Dermatological Angiology
Na Konvářce 6
150 00 Prague 5, Czech Republic
Phone
+420 251 555 899
Fax
+420 323 631 821
E-mail
[email protected]
Congress President
Mitchel P. Goldman, MD
Spa MD
7630 Fay Avenue
La Jolla, California, 92037 USA
Phone
+1 858 459 7011
Fax
+1 858 459 7017
E-mail
[email protected]
Honorary Presidents
Claudio Allegra, Italy
George Fegan, Ireland
Hugo Partsch, Austria
International Scientific Committee
Eberhard Rabe, Germany (Chairman)
V. Blazek, Germany
F.X. Breu, Germany
W.P. Bundens, USA
A. Cornu-Thenard, France
M.D. Forrestal, USA
H.S. Fronek, USA
A. Frullini, Italy
G. Gallenkemper, Germany
H.E. Gerlach, Germany
J.J. Guex, France
A. Jawien, Poland
M. Jünger, Germany
M. Neumann, Netherlands
A. Oesch, Switzerland
A.A. Ramelet, Switzerland
P. Raymond-Martimbeau, Canada
Z. Rybak, Poland
S. Schuller-Petrovic, Austria
A. Scuderi, Brasil
V. Štvrtinová, Slovak Republic
4
Committees & Contacts
Executive Board of the Czech Phlebological Society
and Local Organizing Commmittee
Jaroslav Strejček (Chairman)
Jaromír Seyček (Honorary Chairman)
A. Pospíšilová (Scientific Secretary)
S. Kašpar
K. Benda
I. Přerovský
K. Roztočil
J. Spáčil
J. Zeman
Scientific Secretariat
Kateřina Strejčková
Na Konvářce 6
150 00 Prague 5, Czech Republic
Phone + Fax +420 251 555 899
Mobile
+420 776 329 238
E-mail
[email protected]
Technical Organization + Hotel Reservation
Congress Business Travel Ltd. (CBT)
Lidická 43/66
150 00 Prague 5, Czech Republic
Phone
+420 224 942 575
+420 224 942 579
Fax
+420 224 942 550
E-mail
[email protected]
[email protected]
5
Compression Products
¾ Glamour
¾ Cotton 200
¾ Traditional 500
¾ Top Fine 700
¾ Arm-slleve
Prevention
¾ SAMSON® & DELILAH®
Elastic Bandage
General Agency
in the Czech Republik:
HEINDL spol. s r. o.
Hospital Na Homolce, Rehabilitation
Roentgenova 2
150 30 Prag 5 – Motol
tel. +420 257 272 323, +420 257 272 135
fax +420 257 214 207
e-mail: [email protected]
www.sigvaris.cz
!' !
SIGVARIS Medical Compression Stockings and Pantyhose
are available in four compression classes and in a variety
of qualities, styles and colours. All models are available
in the proven SIGVARIS size range, with a medically
correct, graduated compression according
to the GZG/RAL guidelines.
£
GANZONI & CIE AG , St. Gallen
Sponsors
Exhibitors
BIOLITEC
BOEHRINGER INGELHEIM
DEONA MEDI
EKO – VUK
ELCAT
G.P.S. Ofa
HARTMANN – RICO
HEINDL
IBI INTERNATIONAL
IZIP
LOANA
LOHMANN & RAUSCHER
MEDI BAYREUTH
MEDICOM INTERNATIONAL
NOVARTIS, Consumer Health
RICHTER & ROTHE
SERVIER
STD PHARMACEUTICAL PRODUCTS
VARITEX
WALMARK
7
General Information
Location:
Prague Congress Centre
Panorama Hall, 1st floor, entrance No. 4
5. května 65
140 21 Prague 4, Czech Republic
Phone: +420 261 177 011
Metro line C - “Vyšehrad” station
Office hours at the registration and information desk in the Prague Congress Centre:
Thursday, May 26
14.00 – 19.30
Friday, May 27
08.00 – 17.30
Saturday, May 28
08.00 – 17.30
8
Social and Tourist Programme
May 26th, 2005 - Thursday
Opening Ceremony 19.30
including concert and buffet
Carolinum, Charles University
Ovocný trh 3/5, Prague 1
(incl. in the registration fee of participants
and accompanying persons)
sponsored by
Medicom International
May 27th, 2005 - Friday
City Tour of Prague 9.00 - 13.00
(incl. in the registration fee of
accompanying persons)
meeting point at the registration
at 8.45
Beer Party 20.00
Restaurant “U Kalicha”
Na Bojišti 12–14, Prague 2
sponsored by
IBI International / Kreussler Pharma
9
Programme
May 26 - Thursday
14.00 – 19.30
Registration of participants, installation of posters and exhibition
19.30
Opening Ceremony
Carolinum, Charles University, Ovocný trh 3/5, Prague 1
May 27 - Friday
8.30 – 8.45
Welcome and Opening Remarks: Strejček J., Goldman M.P.
8.45 – 9.15
Keynote Lectures
Chairmen: Strejček J. – Goldman M.P.
1. Phlebology Schools under the Umbrella of UIP
Allegra C. (Italy)
2. Different Risk Factors for Varicose Veins and Chronic Venous Insufficiency?
Rabe E., Pannier-Fischer F., Bock E., Stang A., Bromen K., Jöckel K.H. (Germany)
9.15 – 10.00
Abstract sessions / Venous Anatomy, Physiology and Pathophysiology
Chairmen: Rabe E. – Kočová J.
3.
Vena Fossa Poplitea, an Often Unrecognized and under Appreciated Vein
Raes M.P.E., Kockaert M.A., Neumann H.A.M. (The Netherlands)
4.
Dysplasic Veins of the Saphenous Compartments
Georgiev M. (Italy)
5.
Venous Pressure Dynamics of the Healthy Human Leg
Rudofsky G., Kügler Ch., Strunk M. (Germany)
10.00 - 10.30
Coffee break and exhibition visit
11
Programme
10.30 – 12.15
Abstract sessions / Compression
Chairmen: Partsch H. – Gerlach H.E.
6.
Narrowing of Veins by Compression Stockings Demonstrated by Duplex
Planta I., Jeanneret C. (Switzerland)
7.
Do We Still Need Compression Bandages?
Partsch H. (Austria)
8.
Compression Therapy for Acute Deep Vein Thrombosis
Blättler W., Gerlach H.E. (Switzerland, Germany)
9.
Pressure and Stiffness with Elastic and Inelastic Compression Materials
Kecelj-Leskovec N. (Slovenia)
10.
Measurement of Interface Pressure Using a Simple Transducer and Date-logger
Rohrer C., Rotsch C. (Austria, Germany)
11.
In Vivo Measurements of Pressure and Stiffness with a New Multi-layer Compression
Kit
Charles H., Damstra R.J., Furst D., Jünger M., Partsch H. (United Kingdom, The
Netherlands, France, Germany, Austria)
12.
Why Does Pressure Decrease with Short Stretch Bandages?
Brouwer E.R., Damstra R.J., Partsch H. (The Netherlands, Austria)
13.
Assessment of Dynamic Pressure Behavior under Medical Compression Stockings and
Its Functional Influence on Peripheral Venous Hemodynamics
Blazek C.R., Blazek V. (Germany)
12.15 – 13.15
Lunch break
13.15 – 15.15
Abstract sessions / Sclerotherapy - Foam Sclerotherapy
Chairmen: Goldman M.P. – Guex J.-J. – Breu F.X.
14.
Notes on the Historical Development of Sclerosing Foams
Wollmann J.-C. (Germany)
12
Programme
15.
Telangiectases and Foam: Treatment and Side Effects
Sadoun S. (France)
16.
Efficacy of Lauromacrogol Foam vs. Liquid in Sclerotherapy of the Greater Saphenous
Vein: a Two-year Follow-up
Ouvry P., Allaert F.-A., Hamel-Desnos C. (France)
17.
A European Consensus Meeting on Foam Sclerotherapy, April 2003, Tegernsee,
Germany
Breu F.X., Guggenbichler S. (Germany)
18.
Survey on the Use of Foam Sclerotherapy in 2005
Guggenbichler S., Breu F.X. (Germany)
19.
Proposal for the Standardisation of Preparation and Use of Sclerosing Foam
Wollmann J.-C. (Germany)
20.
Blood Flow in Perforating Arteries Can Change after Oblation of Incompetent
Perforating Veins – Preliminary Ultrasound Observations
Lurie F., Kessler D., Puggioni A., Masuda E. (USA)
21.
Simultaneous Echocardiography with Ultrasound Guided Foam Sclerotherapy
Morrison N., Neuhardt D.L., Knopf K. (USA)
22.
Complications of Sclerotherapy – Prevention and Treatment
Žernovický F., Sámelová K., Žernovický F.jr. (Slovak Rebublic)
23.
Untoward Events after Sclerotherapy of Varicose Veins of the Lower Limbs – Report of
a Multi-centre Registry of 12 173 Sessions
Guex J.-J., Allaert F.-A., Gillet J.-L., Chleir F. (France)
15.15 – 15.45
Coffee break and exhibition visit
13
Programme
15.45 – 17.30
Abstract sessions / Non-Invasive Evaluation of Venous Diseases
A. Original Papers
Chairmen: Partsch H. – Lurie F.
24.
Segmental Venous Hemodynamics – a New Way to Assess Venous Obstruction with
Duplex Ultrasound
Lurie F., Kistner R.L. (USA)
25.
Pulsed Doppler Sensitivity – Is It Important
Morrison N., Neuhardt D.L., Pohle-Schulze B., Fiock S. (USA)
26.
The Functional Doppler Test with the Flat Probe
Várady Z., Böhm Z. (Germany)
27.
Non-Invasive Detection of the Endothelial Activity
Strejček J., Fronek A. (Czech Republic, USA)
B. Current Clinical Practice – Is Duplex All We Need?
Chairmen: Bundens W.P. – Blazek V.
Introduction – Bundens W.P. (USA)
28.
Ultrasound Duplex Is All We Need in Our Clinics and Vascular Labs
Jawien A. (Poland)
29.
Photoplethysmography (PPG) – Proven Venous Examination Tests and Latest
Developments
Blazek V. (Germany)
30.
Quantitative Assessment of Venous Pumping Function
Partsch H. (Austria)
31.
CW Doppler – Its Place in Our Clinics
Bundens W.P. (USA)
Questions and Panel Discussion
20.00
Beer Party
Restaurant “U Kalicha”, Na Bojišti 12-14, Prague 2
14
Programme
May 28 - Saturday
8.30 – 9.00
Keynote Lectures
Chairmen: Goldman M.P. – Strejček J.
32.
Evidence Based Medicine and Veno-active Drugs
Ramelet A.A. (Switzerland)
33.
A Combined Management of Varicose Syndrome – a Prospective Study
Scuderi A., Scuderi P., Scuderi M.A. (Brazil)
9.00 – 10.00
Abstract sessions / Venous Thrombosis
Chairmen: Ramelet A.A. – Scuderi A. – Zeman J.
34.
Prophylaxis of Deep Venous Thrombosis – Role of Heparine-induced
Thrombocytopenia
Traska T. & J.C., Berg W., Hohlbach G., Claeys L. (Germany)
35.
D-Dimer Levels after Hip-joint Replacement
Zeman J., Kubeš R., Štědrý V., Živna P., Dungl P. (Czech Republic)
36.
Implementation of Outpatient Treatment of Deep-vein Thrombosis in German
Centers of Phlebology
Gerlach H.E., Blättler W. (Germany, Switzerland)
37.
Endovascular Treatment of Subclavian-axillary Vein Thrombosis and Superior Vena
Cava Compression
Lesný P., Vulev I., Vozár M., Tomka J., Šefránek V., Prečinský P. (Slovak Republic)
10.00 – 10.30
Coffee break and exhibition visit
10.30– 12.15
Abstract sessions / Endovenous Procedures and Laser Treatment
Chairmen: Schuller-Petrovic S. – Kabnick L.S. – Kašpar S.
38.
Catheter-assisted Vein Sclerotherapy (CAVS) – a New Approach for Sclerotherapy of
the Greater Saphenous Vein
Brodersen J., Geismar U., Kapp A. (Germany)
15
Programme
39.
Two-year Follow-up after EndoVenous Radiofrequency Obliteration (Closure) versus
Ligation and Vein Stripping: a Prospective Randomized Multicenter Study (EVOLVeS)
Schuller-Petrovic S., Lurie F., Creton D., Eklof B., Kabnick L.S., Kistner R.L., Pichot
O., Sessa C., Kern T. (Austria, USA, France)
40.
Morphological Changes in Rabbit’s Veins Following Laser Therapy
Veverková L., Kalač J., Čapov I., Wechsler J., Páč L., Svíženská I., Pitr V. (Czech
Republic)
41.
EndoLaser Venous System (980 nm) for the Treatment of Saphenous Venous
Insufficiency: 7611 Limbs
Kabnick L.S. (USA)
42.
Mid-term Results with the 980 nm Endovenous Laser – the Czech Experience
Kašpar S. (Czech Republic)
43.
Endovenous Laser Treatment of the Greater Saphenous Vein: the Rotterdam
Experience
Roest R.W., Kockaert M.A., Tank B., Neumann H.A.M. (The Netherlands)
44.
1320 nm Laser for Endovenous Ablation
Goldman M.P. (USA)
45.
Implantation of Venous Port-systems – Role and Prevention of Infectious
Complications
Traska T. & J.C., Berg W., Hohlbach G., Claeys L. (Germany)
12.15 – 13.15
Lunch break
13.15 – 14.30
Abstract sessions / Session of the Polish Society of Phlebology
Chairmen: Jawien A. – Strejček J.
46.
History of Phlebology in Poland
Jawien A. (Poland)
47.
Calf Muscle Pump Impairment as the Independent Factor of Delayed Healing of
Venous Leg Ulcers – Air-plethysmographic Findings
Simka M. (Poland)
16
Programme
48.
Evaluation of the Safety of Long Term Secondary Prophylaxis with Low Molecular
Weight Heparins in Patients with Chronic Venous Insufficiency
Cencora M., Chwala M. (Poland)
49.
Reentry Ways and Functional Condition of Perforator in Varicose Disease
Winczakiewicz J., Borkiewicz M. (Poland)
50.
Proximal Deep Vein Thrombosis – 10 Years after
Ziaja K., Urbanek T., Ludyga T., Ziaja D., Biolik G., Kucharzewski M., Szaniewski
K. (Poland)
14.30 – 15.00
Coffee break and exhibition visit
15.00 – 16.30
Abstract sessions / Varia
Chairmen: Štvrtinová V. – Benda K.
51.
Iatrogenic Edema of the Lower Limbs
Georgiev M. (Italy)
52.
Ethics in Communication with Phlebological Out-patients – Why and How
Benda K., Bendová M. (Czech Republic)
53.
Laser Treatment in Chronic Non Healing Leg Ulcers
Casoni P. (Italy)
54.
The Injection Enzymotherapy of the Recurrent Erysipelas
Němcová A., Němcová D. (Czech Republic)
55.
The Vein Injuries – Our Experiences from the Period 1994-2004
Marušiak J., Štrincl J., Rambousek Z., Bureš Z. (Czech Republic)
56.
Prevalence of CVD Symptoms in 3 134 Patients and Their Relation to the Clinical
Stage of the CEAP Classification
Štvrtinová V. (Slovak Republic)
17
Dlouhodobá léčba žilních obtíží?
Venoruton forte
n Léčba chronické žilní insuficience, hemoroidů,
lymfedému a celé řady dalších indikací.
n Velmi dobrá tolerance bez známých
interakcí.
n Schválen i pro těhotné ženy od 4. měsíce
a kojící matky.
n Jednoduché dávkování při léčbě CHŽI.
U minimální udržovací léčby se užívá pouze
1 tableta denně.
n Přijatelná cena pro pacienta s CHŽI.
Doplatek pacienta na měsíční udržovací
léčbu CHŽI při dávkování 1 x 1 je pouze
117 Kč*.
n Snížení nákladů na preskripci u léčby CHŽI.
Náklady na pojišovnu na měsíční udržovací
léčbu jednoho pacienta (při dávkování 1 × 1)
jsou jedny z nejnižších – pouze 45 Kč*.
1 tableta Venorutonu forte obsahuje 500 mg oxerutinu. Oxerutin je standardizovaná směs hydroxylovaných
bioflavonoidů – derivátů rutinu. Hydroxylace zlepšuje jejich rozpustnost ve vodě a snižuje vazbu na proteiny.
VENORUTON FORTE
Složení: Oxerutinum (= ox.) 500 mg v jedné tabletě. Indikace a dávkování: Dospělí, mladiství a děti od 12 let věku: Chronická žilní
insuficience a hemoroidy: Úvodní dávka 1000 mg ox. denně, rozdělená do 2 dílčích dávek po 500 mg. Ke zmírnění příznaků dochází obvykle během 2 týdnů. Pokračuje se ve stejném dávkování do úplného odeznění příznaků. Poté možno léčbu přerušit. Při recidivě příznaků
znovu zahájit léčbu podáváním stejných dávek. Nebo po úplném odeznění příznaků pokračovat v udržovací léčbě podáváním stejných
dávek jako při úvodní léčbě nebo podáváním minimálních udržovacích dávek ve výši 500 mg ox. 1krát denně. Adjuvantní léčba bércových
vředů u pacientů s elastickou bandáží končetin: 500 mg ox. 3krát denně. Lymfedém: 1000 mg ox. ráno, v poledne a večer. Diabetická
retinopatie: 1000 mg ox. 3krát denně. Prevence nežádoucích reakcí při radioterapii: 500 mg ox. 3krát denně. Posttrombotický syndrom,
varikózní dermatitida: Obvykle 500 mg ox. 2krát denně po dobu trvání obtíží. Způsob podání: Tablety se užívají během jídla a zapíjejí
se trochou tekutiny. Kontraindikace: Přecitlivělost na složky přípravku, 1. trimestr gravidity, děti mladší 12 let. Zvláštní upozornění:
Toleranční studie u pacientů s insuficiencí jater nebo ledvin a u velmi starých pacientů neprokázaly žádné známky významné intolerance
oxerutinu. Interakce: Nejsou známy. Těhotenství a kojení: Doporučuje se, aby nebyl podáván v 1. trimestru těhotenství. Od 4. měsíce
těhotenství a v období kojení je možné podávat. Možnost snížení
pozornosti: Neovlivňuje. Nežádoucí účinky: Pouze mírné – kožní
vyrážky, mírné gastrointestinální obtíže, bolesti hlavy a návaly, které
po přerušení léčby rychle odezněly. Předávkování: Nejsou známy
žádné příznaky. Uchovávání: Za obyčejné teploty, chránit před vlhkem. Držitel rozhodnutí o registraci: Novartis s.r.o., Praha, Česká
republika Registrační číslo: Venoruton forte: 85/244/95-C. Datum
poslední revize textu: 18.2.2004. Přípravek je částečně hrazen zdravotní pojišťovnou. Je i volně prodejný.
* vychází z ceny přípravku dle číselníku VZP, s účinností od 1.1.2005
Novartis s.r.o., Consumer Health
U Nákladového nádraží 10, 130 00 Praha 3
Na recept i volně prodejný
Posters
Visiting posters with authors:
May 27, 15.15 – 15.45
May 28, 10.00 – 10.30
P1. Microcirculation in Venous Ulcers and the Surrounding Skin
Ambrózy E., Gschwandtner M.E., Fashing S., Willfort A., Ehringer H. (Slovak
Republic, Austria)
P2. The Significance of the Genetic Examinations in Patient with Deep Vein Thrombosis
Brůhová H., Štěpánková L. (Czech Republic)
P3. Ultrasound Guided Sclerotherapy with Polidocanol in Microfoam for the Treatment of
Varicose Long Saphenous Veins - Experience in More than 500 Legs
Fernández-Alonso L., Sierra A., Lloret P., Rodríguez-Spiteri N., Mejía S., Urtasun R.,
Carasusán A. (Spain)
P4. Antiseptic Elastic Support Stocking in Therapy of Advanced Chronic Venous
Insufficiency
Herman J. (Czech Republic)
P5. Venous Wall Remodeling and Fibrinolytic Components
Křížková V., Kočová J., Korabečná M., Horáková M.A. (Czech Republic)
P6. A Case of Primary Lymphedema Presenting after Vaccination
Machovcová A., Hýblerová K., Křížová H. (Czech Republic)
P7. Congenital Venous Malformations – Syndrome of Klippel-Trenaunay and Syndrome
of Weber
Mazuch J., Mištuna D., Huľo E., Gatialová K. (Slovak Republic)
P8. Some Anatomical, Physiological and Pathophysiological Aspects of Chronic Venous
Insufficiency
Nechvátal A. (Czech Republic)
P9. The Superficial Thrombophlebitis – Report on a Cohort of 63 Patients
Oettler W.J., Halbritter K., Beyer J., Faulmann G., Lißke P., Schwarz T., Schellong
S.M. (Germany)
19
Posters
P10. Epidemiology of Primary Chronic Venous Insufficiency (CVI), Stages 0, I and II
(CEAP Classification) – Lights and Shadows
Rada F.C., Cristodor P., Ciobanas D., Parvan L., Mihoc T., Blaj S., Rada I.O.
(Romania)
P11. Complications of Chronic Venous Insufficientia
Rajczyová J., Jautová J. (Slovak Republic)
P12. Prospective Randomized Trial to Determine the Adequate Grade of Compression after
Sclerotherapy for Varicose Veins
Sierra A., Fernández-Alonso L., Lloret P., Rodríguez-Spiteri N., Mejía S., Urtasun R.,
Carasusán A. (Spain)
P13. Lyophilized Cultured Epidermal Allografts in the Treatment of Chronic Venous Leg
Ulcer
Slonková V., Navrátilová Z., Semrádová V., Adler J. (Czech Republic)
List of Presenting Authors
ALLEGRA Claudio, Prof., Via del Collosseo 26, 00185 Roma, Italy, E-mail: [email protected]
AMBRÓZY Ewald, MUDr., 2nd Internal Clinic of Commenius University, Mickiewiczova 13,
813 69 Bratislava, Slovak Republic, E-mail: [email protected]
BENDA Karel, Prof. MUDr. DrSc., Radiologická klinika, FN Brno-Bohunice, Jihlavská 20,
625 00 Brno-Bohunice, Czech Republic, E-mail: [email protected]
BLÄTTLER Werner, MD, Center for Vascular Diseases, Angio Bellaria, Bellariastr. 40,
CH-8038 Zürich, Switzerland, E-mail: [email protected]
BLAZEK Claudia R., cand. med., Dept. of Dermatology, University Hospital, Aachen University
RWTH, Melatener Str. 25, D-52056 Aachen, Germany, E-mail: [email protected]
BLAZEK Vladimir, Prof. Dr.-Ing. Dr. h.c., Insitute of High Frequency Technology, Aachen University
RWTH, Melatener Str. 25, D-52056 Aachen, Germany, E-mail: [email protected]
BREU Franz Xaver, Dr. med., Tegernsee Str. 101, D-83700 Rottach-Egern, Tegernsee, Germany,
E-mail: [email protected]
BRODERSEN Jens Dr. med., Hautklinik Linden, Ricklinger Str. 5, D-30449 Hannover, Germany,
E-mail: [email protected]
BROUWER Els W., MD, Nij Smellinghe hospital, Compagnonsplein 1, 9202 NN, Drachten,
The Netherlands, E-mail: [email protected]
BRŮHOVÁ Hana, MUDr., I. interní klinika FN Plzeň, alej Svobody 80, 304 60 Plzeň,
Czech Republic, E-mail: [email protected]
BUNDENS Werner P., MD, MS, 15822 Lime Grove Rd., Poway, CA-92064, USA,
E-mail: [email protected]
CASONI Paolo, MD, Italy, E-mail: [email protected]
CHARLES Hildegard, MD, London, United Kingdom, E-mail: [email protected]
20
List of Presenting Authors
CHWALA Maciej, MD, Dept. of Vascular Diseases, Jagiellonian University, Trynitanska 11
str., 31-061 Cracow, Poland, E-mail: [email protected]
FERNÁNDEZ-ALONSO Leopoldo, Dr.med., Phlebology Unit, University Clinic of Navarra,
Avda. Pio XII 36, 31008 Pamplona, Spain
GEORGIEV Mihael, MD, FACPH, Via Rosetti 1, 04100 Latina, Italy, E-mail: [email protected]
GERLACH Horst E., Dr. med., T 6/25, D-68161 Mannheim, Germany,
E-mail: [email protected]
GOLDMAN Mitchel P., MD, Spa MD, 7630 Fay Avenue, La Jolla, CA 92037, USA,
E-mail: [email protected]
GUEX Jean-Jérome, MD, FACPH, 32 Bd. Debouchage, 06000 Nice, France,
E-mail: [email protected]
GUGGENBICHLER Stephan, Dr.med., Frauenstr. 17, D-80469 München, Germany,
E-mail: [email protected]
HERMAN Jiří, Doc. MUDr. PhD., 2. Dept. of surgery, Hospital and Medical Faculty of Palacky
University, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic, E-mail: [email protected]
HÝBLEROVÁ Kateřina, MUDr., Dept. of Dermatology, Faculty Hospital Motol, V Úvalu 84,
150 00 Praha 5, Czech Republic, E-mail: [email protected]
JAWIEN Arkadiusz, Prof. Dr. med., L. Rydygier University Medical School, Bydgoszcz, Poland,
E-mail: [email protected]
KABNICK Lowell S., MD, FACS, Vein Institute of New Jersey, 95 Madison Avenue, Suite 109,
Morristown, NJ 07960, USA, E-mail: [email protected]
KAŠPAR Svatopluk, MUDr., Flebocentrum, Líznerova 737, 500 09 Hradec Králové, Czech Republic,
E-mail: [email protected]
KECELJ-LESKOVEC Nada, MD, Department of Dermatovenereology, University Medical Centre,
Ljubljana, Slovenia, E-mail: [email protected]
KŘÍŽKOVÁ Věra, MUDr. PhD., Dept. of Histology, Faculty of Medicine in Pilsen, Charles
University, Karlovarská 48, 301 66 Plzeň, Czech Republic, E-mail: [email protected]
LESNÝ Pavol, MUDr., Slovak Institute of Heart and Vessel Diseases, Pod Krásnou Horkou 1,
833 48 Bratislava, Slovak Republic, E-mail: [email protected]
LURIE Fedor, Prof., MD, Dept. of Surgery, University of Hawaii, 425 South Street, Suite 2503,
96813 Honolulu, USA, E-mail: [email protected]
MARUŠIAK Jan, MUDr. PhD., Dept. Of Vascular and Reconstructive Surgery, General Teaching
Hospital, Husova 10, 460 01 Liberec, Czech Republic, E-mail: [email protected]
MAZUCH Július, Prof. MUDr. DrSc., Medical Faculty of Jessenius, University of Commenius,
Kollárova 2, 036 01 Martin, Slovak Republic, E-mail: [email protected]
MORRISON Nick, MD, 9755 N. 90th Street #A-210, Scottsdale, AZ 85258, USA,
E-mail: [email protected]
NECHVÁTAL Antonín, MUDr., Dermatovenerologické oddělení, FN v Motole, V Úvalu 84,
150 00 Praha 5, Czech Republic, E-mail: [email protected]
NĚMCOVÁ Alexandera, MUDr., Dermatologic Out-patient Practice, ČSA 6a, 74801 Hlučín,
Czech Republic, E-mail: [email protected]
OETTLER Wolfram, MD, Dept. of Angiology, University Hospital of Dresden, Fetscherstr. 74,
D-01307 Dresden, Germany, E-mail: [email protected]
OUVRY Pierre, MD, Cabinet d’angiologie, 9 Rue Jules Ferry, Dieppe, France,
E-mail: [email protected]
PARTSCH Hugo, Prof. Dr. med., Baumeistergasse 85, A-1160 Wien, Austria,
E-mail: [email protected]
von PLANTA Irene, Dr. med., Praxis of Vascular Medicine, St. Johanns-Vorstadt 44, CH-4056 Basel,
Switzerland, E-mail: [email protected]
21
List of Presenting Authors
RABE Eberhard, Prof. Dr. med., Klinik und Poliklinik für Dermatologie, Rheinische FriedrichWilhelms Universität, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany,
E-mail: [email protected]
RADA I. Octavian, Consultant Prof., Romanian Society of Lymphology, Siret-Ion-Viak 406,
1900 Timisoara, Romania, E-mail: [email protected]
RAES Melanie P.E., MD, Dept. of Dermatology and Venereology, Erasmus MC, PO-BOX 2040,
3000 CA, Rotterdam, The Netherlands, E-mail: [email protected]
RAMELET Albert-Adrian, MD, 2 Place Benjamin-Constant, CH-1003 Lausanne, Switzerland,
E-mail: [email protected]
RAJCZYOVÁ Jana, MUDr., Klinika Dermatovenerologie LF UPJS a FNLP, Tr. SNP I, 040 66 Košice,
Slovak Republic, E-mail: [email protected]
ROEST R.W., MD, Dept. of Dermatology and Venereology, Erasmus MC, PO-BOX 2040, 3000 CA,
Rotterdam, The Netherlands, E-mail: [email protected]
ROHRER Christian, Dr. med., Research & Development, Lohmann und Rauscher GmbH,
Kirchengasse 17, A-2525 Schönau, Austria, E-mail: [email protected]
RUDOFSKY Gottfried, Prof. Dr. med. Prof. h.c., Klinik und Poliklinik für Angiologie,
Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen,
E-mail: [email protected]
SADOUN Symon, MD, Hopital Tenon, 4 Rue de la Chine, 75020 Paris, France,
E-mail: [email protected]
SCHULLER-PETROVIC Sanja, MD, Ph.D., Alserstr. 47, A-1190 Wien, Austria,
E-mail: [email protected]
SCUDERI Angelo, MD, INSPEMOC, Rue Santa Clara 494, Sorocaba, 18030-421, Brazil,
E-mail: [email protected]
SIERRA-MARTINEZ Alejandro, Dr. med., Phlebology Unit, University Clinic of Navarra, Avda. Pio
XII 36, 31008 Pamplona, Spain, E-mail: [email protected]
SIMKA Marian, MD, ul. Jednosci 20, Studzionka, Poland, E-mail: [email protected]
SLONKOVÁ Veronika, MUDr., Dept. of Dermatovenereology, St. Anna University Hospital,
Pekařská 53, 602 00 Brno, Czech Republic, E-mail: [email protected]
STREJČEK Jaroslav, MUDr. PhD., Center for Dermatological Angiology, Na Konvářce 6, 150 00
Praha 5, Czech Republic, E-mail: [email protected]
ŠTVRTINOVÁ Viera, Prof. MUDr. PhD., 2nd Internal Clinic of Commenius University,
Mickiewiczova 13, 813 69 Bratislava, Slovak Republic, E-mail: [email protected]
SZANIEWSKI Krzysztof, MD, Dept. of General and Vascular Surgery, Medical University of Silesia,
Ziolowa 45/47, 40-635 Katowice, Poland
TRASKA Thilo, Dr. med., Dept. of Surgery, Marienhospital Herne, Hölkeskampring 40, D-44626
Herne, Germany, E-mail: [email protected]
VÁRADY Zoltán, Prof. Dr., Venenklinik, Zeil 123, D-60313, Frankfurt, Germany,
E-mail: [email protected]
VEVERKOVÁ Lenka, MUDr., 1st Surgical Dept., St. Anna University Hospital, Pekařská 53,
602 00 Brno, Czech Republic, E-mail: [email protected]
WINCZAKIEWICZ Jacek, MD, Prywatne Centrum Chirurgii, Ul. Kollataja 10a, 87-100 Torun,
Poland, E-mail: [email protected]
WOLLMANN Jan-Christoph, Dr. med., Kreussler Pharma, Rheingaustr. 87-93, D-65203 Wiesbaden,
Germany, E-mail: [email protected]
ZEMAN Jan, MUDr., Dept. of Clinical Angiology, Budínova 2, 180 00 Praha 8, Czech Republic,
E-mail: [email protected]
ŽERNOVICKÝ František, Doc. MUDr. CSc., Angio Bratislava, Parcelná 9, 821 06 Bratislava,
Slovak Republic, E-mail: [email protected]
22
Aethoxysklerol
®
injekční roztok ke sklerotizaci varixů
Výhradní zastoupení a distribuce v ČR
– International spol. s r.o.
Senovážné nám. 5, 110 00 Praha 1
Tel.: 281 028 230, fax: 281 028 232
e-mail: [email protected], www.ibi.cz
medi. I feel better.
We present all our activities, our products and our corporate
communication under this motto with the aim of offering essential
benefits for our partners and users.
www.medi.de
Visit us at the 6th European American Congress on Venous Diseases,
Prague, from 26th - 28th May 2005